1ABBV:BIT
AbbVie Common Stock
âĴ216.80
arrow_downward
-0.96%(-2.10) 1D
Sep 8, 5:26:00âŻPM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1ABBV...
Open
âĴ220.60
High
âĴ220.60
Low
âĴ215.20
Mkt. cap
439.62B
Avg. vol.
34.00
Volume
26.00
52-wk high
âĴ234.70
52-wk low
âĴ168.00
No. of employees
57K
Open
âĴ220.60
High
âĴ220.60
Low
âĴ215.20
Mkt. cap
439.62B
Avg. vol.
34.00
Volume
26.00
52-wk high
âĴ234.70
52-wk low
âĴ168.00
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
3 hours ago
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now
Trefis
·
3 hours ago
Is AbbVie Stock Too Reliant On Skyrizi?
Investing.com
·
9 hours ago
BofA raises Abbvie stock price target on Apogee deal close
AD HOC NEWS
·
2 days ago
AbbVie Inc. stock holds near highs as Apogee deal and guidance support sentiment
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com